American Journal of Translational Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2022-12-03 我真爱学习来自浙江省

同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。
另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2022-09-26 wjc

已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2021-03-22 123934bbm39(暂无昵称)

投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃

89 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2020-10-09 科研小王子66

审稿速度:2.0 | 投稿命中率:50.0
经验分享：#肿瘤#非常不错的期刊，很友好

651 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2021-03-01 1247f785m03(暂无昵称)

今年的文章web of science都没有收录，是咋个回事？

104 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2020-05-01 147081b6m01(暂无昵称)

审稿速度:6.0 | 投稿命中率:25.0
经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。

309 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2020-04-09 1410505444_73620560

审稿速度:6.0
经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了

97 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2020-05-21 171454390

目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了

87 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2023-02-07 ms5000001207401255 来自广西

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;生信分析
经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104172, encodeId=f70421041e2a4, content=同志们，这个编辑让我润色，润色公司是江苏的，我也是醉了。这是国人主编，还是有合作啊？同时我想问问润色后接受度高不高？花了钱不接受不是很痛苦。 另外纯META关于肿瘤药物的有没有推荐的杂志啊？感谢感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=004b5567409, createdName=我真爱学习, createdTime=Sat Dec 03 23:03:34 CST 2022, time=2022-12-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2090529, encodeId=81db2090529a2, content=已经交过版面费2周了，一直显示unpaid，给编辑部发邮件也不回复，是怎么回事？有老师知道大概流程吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0d41710359, createdName=wjc, createdTime=Mon Sep 26 22:16:23 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950194, encodeId=8a7095019404, content=投稿整三个月了，一点动静都没有，写催稿信倒是回复快，不过只说尽快给编辑的决定，等于没说🙃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=705f2419753, createdName=123934bbm39(暂无昵称), createdTime=Mon Mar 22 21:44:10 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890670, encodeId=23f78906e022, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>非常不错的期刊，很友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=651, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Fri Oct 09 01:48:49 CST 2020, time=2020-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944514, encodeId=9f82944514b7, content=今年的文章web of science都没有收录，是咋个回事？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Mon Mar 01 17:21:55 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590069, encodeId=1166590069f2, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：投稿四个月，然后被拒。感觉根本没送审，毕业前请绕道。中间无论怎么催编辑，连个基本礼貌性回复都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=309, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c75185940, createdName=147081b6m01(暂无昵称), createdTime=Fri May 01 00:00:00 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588471, encodeId=4f5d5884e138, content=审稿速度:6.0 经验分享：9月投稿，一审2个月多，给的大修，花了半个月补好，复审花了3个月！！期间发多次邮件不回，一度以为杂志社疫情不开了，最终终于接收了。交钱也只能电汇不能信用卡！现在交完钱邮件告诉我1-2个月发给我校样，我尼玛。慎投！尤其是毕业生，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=251f5317465, createdName=1410505444_73620560, createdTime=Thu Apr 09 01:17:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591377, encodeId=32b35913e73e, content=目前修回再投一个月了还没收到回复不知道还要多久应该赶不上第一批答辩了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f873065437, createdName=171454390, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113527, encodeId=b81a211352e11, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信分析 经验分享：2023年还是别投了，IF20年4.06,21年3.94，22年1.96，就没见过那么骚的杂志。不如Oncology Letters还有Oncology Reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6858365730, createdName=ms5000001207401255, createdTime=Tue Feb 07 20:36:28 CST 2023, time=2023-02-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096577, encodeId=256920965e7a2, content=请问，这个还收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94916540576, createdName=ms5000000745293502, createdTime=Thu Oct 27 23:41:41 CST 2022, time=2022-10-27, status=1, ipAttribution=)]

2022-10-27 ms5000000745293502

请问，这个还收纯生信吗

49 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务